Abstract
In an open-label prospective study to investigate the effects of clarithromycin on oral mucositis in bone marrow transplant (BMT) recipients, one group of patients received clarithromycin from day -7 until engraftment. The number of patients with severe mucositis in the control group was significantly higher than that in the clarithromycin group (p<0.05).
Original language | English |
---|---|
Pages (from-to) | 554-555 |
Number of pages | 2 |
Journal | Haematologica |
Volume | 86 |
Issue number | 5 |
Publication status | Published - May 2001 |
Externally published | Yes |
ASJC Scopus Subject Areas
- Hematology
Keywords
- Bone marrow transplant
- Clarithromycin
- Oral mucositis